FY2025 · period end Dec '25 · from the 10-K filed Feb 24, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $19.63B | $19.34B | $19.45B | $19.40B | $17.62B |
| Gross Profit | $5.03B | $4.76B | $4.93B | $5.31B | $5.08B |
| Operating Income | $1.83B | $1.39B | $1.37B | $1.51B | $1.85B |
| Net Income | — | — | — | — | — |
| EPS (Diluted) | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $31.00B | $33.57B | $33.93B | $35.75B | $34.37B |
| Total Liabilities | $16.72B | $17.80B | $19.10B | $20.30B | $20.39B |
| Stockholders' Equity | $14.28B | $15.77B | $14.83B | $15.45B | $13.98B |
| Cash & Equivalents | $1.60B | $1.18B | $1.40B | $1.27B | $1.48B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.68B | $2.39B | $2.63B | $2.17B | $2.49B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 25.6% | 24.6% | 25.3% | 27.4% | 28.8% |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Net Margin | 0.1% | 0.0% | 0.0% | 0.0% | 0.1% |
| Return on Equity | 6.6% | 3.8% | 4.1% | 6.5% | 9.1% |
| Return on Assets | 3.1% | 1.7% | 1.8% | 2.7% | 3.6% |
| Debt / Equity | 0.40× | 0.40× | 0.50× | 0.51× | 0.57× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 20-F | 0001104659-26-019005 | Dec 31, 2025 | Feb 24, 2026 | Feb 24, 2026 17:41 UTC | EDGAR |
| 20-F | 0001104659-25-016784 | Dec 31, 2024 | Feb 25, 2025 | Feb 25, 2025 14:50 UTC | EDGAR |
| 20-F | 0001104659-24-025293 | Dec 31, 2023 | Feb 20, 2024 | Feb 20, 2024 15:02 UTC | EDGAR |
| 20-F | 0001104659-23-024168 | Dec 31, 2022 | Feb 22, 2023 | Feb 22, 2023 15:56 UTC | EDGAR |
| 20-F | 0001104659-22-025549 | Dec 31, 2021 | Feb 22, 2022 | Feb 22, 2022 18:17 UTC | EDGAR |
| 20-F | 0001047469-21-000424 | Dec 31, 2020 | Feb 23, 2021 | Feb 23, 2021 18:51 UTC | EDGAR |
| 20-F | 0001047469-20-000960 | Dec 31, 2019 | Feb 20, 2020 | Feb 20, 2020 18:52 UTC | EDGAR |
| 20-F | 0001047469-19-000562 | Dec 31, 2018 | Feb 20, 2019 | Feb 20, 2019 19:02 UTC | EDGAR |
Direct links to SEC EDGAR. FMCQF has additional filings available on the SEC site.
Who is buying and selling Fresenius Medical Care AG — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on FMCQF yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on FMCQF and publish the result to your public profile.
Ask about Fresenius Medical Care AG
Continue in Workspace — cited answers on FMCQF, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs